ARCHIVES

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

Congress Agrees On $1.989 Bil. FY92 NCI Budget, But Most Of Increase Not Available Till 1993

November 8, 1991

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

Bush May Nominate Zerhouni For NIH Director

March 8, 2002

AACR Honorary Memberships; ASCO Awards

July 20, 1990

Georgetown Sponsors Oncology Agent Development Meeting

February 21, 2003

In Brief: Schmidt Sells OMB On Training Grants, But Weinberger Is The One To Convince

December 21, 1973